Literature DB >> 19780373

Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training.

Jean-claude Jouanin1, Caroline Dussault, Pascal Van Beers, Christophe Piérard, Maurice Beaumont.   

Abstract

OBJECTIVE: We study the effect of short half-life hypnotics (zaleplon or zolpidem against placebo) on altitude tolerance in 12 nonacclimated male soldiers (age, 22.1 +/- 0.8 years; height, 177.8 +/- 1.7 cm; weight, 69.8 +/- 1.7 kg).
METHODS: Soldiers were trained to practice mountaineering at high altitude (2,533-4,810 meters) during 3 periods (one per medication tested) of 4 days (D1-D4). In each period the nights were spent in a hut (3,613 m). Administration of hypnotics or placebo was then implemented at 9:45 p.m. Nocturnal arterial oxygen saturation (SaO2) and heart rate variability (HRV) were monitored. At 5:00 a.m. and 9:00 p.m. physical fitness was assessed using acute mountain sickness (AMS) score. At 5:00 p.m., a posteffort stand test was carried out to evaluate the orthoparasympathetic imbalance with fatigue.
RESULTS: Nocturnal SaO2 correlated negatively with morning AMS scores (R = -0.820, p < 0.02) and HRV analysis favored the sympathetic modulation. Posteffort stand tests revealed that sympathetic modulation attenuated from D2 to D3 in treated groups.
CONCLUSION: The present study provides evidence that zolpidem or zaleplon improves sleep and subsequent physical fitness at altitude.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780373     DOI: 10.7205/milmed-d-03-1708

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  5 in total

1.  Using machine learning to determine the correlation between physiological and environmental parameters and the induction of acute mountain sickness.

Authors:  Chih-Yuan Wei; Ping-Nan Chen; Shih-Sung Lin; Tsai-Wang Huang; Ling-Chun Sun; Chun-Wei Tseng; Ke-Feng Lin
Journal:  BMC Bioinformatics       Date:  2022-05-31       Impact factor: 3.307

2.  Sleep Medication and Athletic Performance-The Evidence for Practitioners and Future Research Directions.

Authors:  Lee Taylor; Bryna C R Chrismas; Ben Dascombe; Karim Chamari; Peter M Fowler
Journal:  Front Physiol       Date:  2016-03-07       Impact factor: 4.566

3.  A hypothesis study on a four-period prevention model for high altitude disease.

Authors:  Xian-Sheng Liu; Xiang-Rong Yang; Lu Liu; Xian-Kui Qin; Yu-Qi Gao
Journal:  Mil Med Res       Date:  2018-01-24

4.  Clinical evaluation of zaleplon in the treatment of insomnia.

Authors:  Marieke M Ebbens; Joris C Verster
Journal:  Nat Sci Sleep       Date:  2010-07-20

5.  Investigation of the usefulness of zaleplon at two doses to induce afternoon-sleep under noise interference and its effects on psychomotor performance and vestibular function.

Authors:  Liang-En Chen; An-Dong Zhao; Qing-Jun Zhang; Feng Wu; Zhao-Li Ge; Hua Ge; Hao Zhan
Journal:  Mil Med Res       Date:  2016-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.